![PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: A randomized study of the Hellenic Oncology Research Group (HORG) PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: A randomized study of the Hellenic Oncology Research Group (HORG)](https://i1.rgstatic.net/publication/26699708_FEC_versus_sequential_docetaxel_followed_by_epirubicincyclophosphamide_as_adjuvant_chemotherapy_in_women_with_axillary_node-positive_early_breast_cancer_A_randomized_study_of_the_Hellenic_Oncology_Res/links/00b7d515d919e84bd1000000/largepreview.png)
PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: A randomized study of the Hellenic Oncology Research Group (HORG)
![ΜΑΛΑΜΟΣ Κ. ΙΩΑΝΝΗΣ / ΥΠΟΨΗΦΙΟΣ ΣΥΜΒΟΥΛΟΣ ΚΟΙΝΟΤΗΤΑΣ ΓΛΩΣΣΑΣ ΤΟΥ ΔΗΜΟΥ ΣΚΟΠΕΛΟΥ | ΔΡΩΜΕΝΑ ΤΟΥ ΤΟΠΟΥ ΜΑΣ ΜΑΛΑΜΟΣ Κ. ΙΩΑΝΝΗΣ / ΥΠΟΨΗΦΙΟΣ ΣΥΜΒΟΥΛΟΣ ΚΟΙΝΟΤΗΤΑΣ ΓΛΩΣΣΑΣ ΤΟΥ ΔΗΜΟΥ ΣΚΟΠΕΛΟΥ | ΔΡΩΜΕΝΑ ΤΟΥ ΤΟΠΟΥ ΜΑΣ](https://1.bp.blogspot.com/-91cecwtn3PA/XOczSd6ALqI/AAAAAAABmS4/IIA7ZU9JgxEZdPYN_S662jhkLyIyFWUUgCLcBGAs/s640/Untitled-1.jpg)
ΜΑΛΑΜΟΣ Κ. ΙΩΑΝΝΗΣ / ΥΠΟΨΗΦΙΟΣ ΣΥΜΒΟΥΛΟΣ ΚΟΙΝΟΤΗΤΑΣ ΓΛΩΣΣΑΣ ΤΟΥ ΔΗΜΟΥ ΣΚΟΠΕΛΟΥ | ΔΡΩΜΕΝΑ ΤΟΥ ΤΟΠΟΥ ΜΑΣ
![Ioannis KOLETSIS | Research Associate | Ph.D. in Meteorology | National Observatory of Athens, Athens | NOA | Institute of Environmental Research and Sustainable Development (IERSD) Ioannis KOLETSIS | Research Associate | Ph.D. in Meteorology | National Observatory of Athens, Athens | NOA | Institute of Environmental Research and Sustainable Development (IERSD)](https://i1.rgstatic.net/ii/profile.image/272273164730390-1441926389821_Q512/Ioannis-Koletsis.jpg)
Ioannis KOLETSIS | Research Associate | Ph.D. in Meteorology | National Observatory of Athens, Athens | NOA | Institute of Environmental Research and Sustainable Development (IERSD)
![PDF) Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG) PDF) Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)](https://i1.rgstatic.net/publication/268450818_Dose-dense_paclitaxel_versus_docetaxel_following_FEC_as_adjuvant_chemotherapy_in_axillary_node-positive_early_breast_cancer_a_multicenter_randomized_study_of_the_Hellenic_Oncology_Research_Group_HORG/links/551ebe220cf29dcabb07a69b/largepreview.png)